Contineum Therapeutics (CTNM) Total Liabilities (2023 - 2026)
Contineum Therapeutics (CTNM) posted quarterly Total Liabilities of $10.7 million for Q2 2026, down 6.88% year-over-year from $11.5 million in Q2 2025, and down 5.31% quarter-over-quarter from $11.3 million in Q1 2026.
Contineum Therapeutics (CTNM) Total Liabilities (2023 - 2026) Analysis & Trends
Contineum Therapeutics' Total Liabilities history runs 4 years deep, the most recent figure standing at $10.7 million for Q2 2026.
- In Q2 2026, Total Liabilities fell 6.88% year-over-year to $10.7 million; the TTM figure through Jun 2026 stood at $10.7 million (down 6.88% YoY), while the FY2025 annual figure was $15.7 million, up 5.9% from the prior year.
- Total Liabilities for Q2 2026 stood at $10.7 million, down from $11.3 million in the prior quarter.
- The five-year high for Total Liabilities was $15.7 million in Q4 2025, with the low at $3.9 million in Q2 2024.
- The 4-year median for Total Liabilities is $10.7 million (2026), against an average of $10.0 million.
- The sharpest annual moves came in 2025 and 2026: Total Liabilities soared 198.49% in 2025, then slipped 16.21% in 2026.
- Contineum Therapeutics' Total Liabilities stood at $5.7 million in 2023, then jumped by 159.22% to $14.8 million in 2024, then climbed by 5.9% to $15.7 million in 2025, then plunged by 31.6% to $10.7 million in 2026.
- Business Quant data shows CTNM's Total Liabilities at $10.7 million in Q2 2026, $11.3 million in Q1 2026, and $15.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Contineum Therapeutics | 533.73 Mn | 533.73 Mn | - | 10.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.71 Mn |
| Mar 31, 2026 | 11.31 Mn |
| Dec 31, 2025 | 15.65 Mn |
| Sep 30, 2025 | 10.38 Mn |
| Jun 30, 2025 | 11.50 Mn |
| Mar 31, 2025 | 13.50 Mn |
| Dec 31, 2024 | 14.78 Mn |
| Sep 30, 2024 | 5.81 Mn |
| Jun 30, 2024 | 3.85 Mn |
| Mar 31, 2024 | 6.57 Mn |
| Dec 31, 2023 | 5.70 Mn |